Morgan Stanley
DMII icon

Morgan Stanley’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Morgan Stanley’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634 Sell
63
-56
-47% -$562 ﹤0.01% 7594
2026
Q1 		$1.19K Sell
119
-50
-30% -$498 ﹤0.01% 7406
2025
Q4 		$1.67K Buy
+169
New +$1.67K ﹤0.01% 7281

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Morgan Stanley's DMII Position: Q2 2026 in Review

Morgan Stanley reduced its Drugs Made In America Acquisition II Corp (DMII) stake by 47% in Q2 2026, selling an estimated $562 and leaving 63 shares worth $634. The position accounts for ﹤0.01% of the portfolio, ranked #7594.

Morgan Stanley first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.67K in Q4 2025. 69 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Morgan Stanley held 63 shares of Drugs Made In America Acquisition II Corp worth $634 as of Q2 2026.
  • Morgan Stanley sold 56 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $562.
  • Drugs Made In America Acquisition II Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7594 holding.
  • Morgan Stanley first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • Morgan Stanley's Drugs Made In America Acquisition II Corp position peaked at $1.67K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.